Glenmark launches Teneligliptin+Dapagliflozin Fixed-Dose Combination for adults with type-II diabetes Read more
Glenmark Pharma, USA continues to expand its OTC portfolio with acquisition of approved ANDAs from Wockhardt Read more
Glenmark Pharma receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate foam Read more
Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination drug for type-II diabetes in India Read more